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Abstract: 
Background 
Obesity rates in long-haul truck drivers have been shown to be significantly higher than the 
general population. We hypothesized that commercial drivers with the highest levels of general 
obesity and abdominal adiposity would have higher concentrations of high sensitivity C-reactive 
protein (CRP), a marker of inflammation. 
Methods 
Survey and anthropometric data were collected from 262 commercial drivers. Weight, 
circumference measures, and blood analysis for CRP (N = 115) were conducted and compared to 
National Health and Nutrition Examination Survey (NHANES) data. CRP values were non-
normally distributed and logarithmically transformed for statistical analyses. 
Results 
BMI, waist circumference, sagittal abdominal diameter, and CRP were significantly higher than 
in the general population. Anthropometric indices that included height (BMI, waist-to-height 
ratio, and sagittal diameter-to-height ratio), were most predictive of CRP values. 
Conclusions 
Abdominal obesity is prevalent in commercial vehicle drivers and is an important indicator of the 
presence of inflammation in this population. 
Keywords: commercial vehicle drivers | obesity | abdominal obesity | cardiovascular disease | 
inflammation| sagittal diameter | high sensitivity C-reactive protein 
Article: 
INTRODUCTION 
In the past decade (2000–2010), the number of deaths attributed to cardiovascular disease (CVD) 
declined 16.7%, but CVD remained the leading cause of death and accounted for 31.9% of all 
deaths in the United States [Go et al., 2013]. Commercial vehicle drivers are exposed to a wide 
array of unique occupationally induced health hazards that have been shown to negatively impact 
health, quality of life and ultimately, longevity [Apostolopoulos et al., 2010]. Particularly for 
long-haul truck drivers, lifestyle and occupational factors such as imposed sedentariness, limited 
availability of healthy dietary options, sleep deprivation, irregular schedules, long work hours, 
and postural fatigue collectively increase job related strain and stress [Robinson and 
Burnett, 2005; Apostolopoulos et al., 2010]. Adverse work characteristics and job strain have 
been related to CVD [Kivimäki et al., 2012; Steptoe and Kivimäki, 2012], and while health-
related behaviors are paramount in CVD risk for all individuals, chronic job strain in long-haul 
truck drivers may affect their physiological stress response [Schnorpfeil et al., 2003], altering the 
hormonal milieu and promoting a pro-inflammatory environment. 
Low-grade systemic inflammation has been linked to several diseases and long-term adverse 
outcomes. Chronic low-grade inflammation has consistently been postulated as the link between 
obesity, type 2 diabetes and cardiovascular disease [Esser et al., 2014; McNelis and 
Olefsky, 2014; Zhou and Pan, 2015]. At a cellular level, the inflammatory process associated 
with obesity is considered “sterile,” since it is produced in response to metabolic rather than 
infectious stimuli and remains at the subacute level, chronically sustained without an adequate 
resolution [McNelis and Olefsky, 2014]. Although the specific precipitating events are not yet 
fully elucidated, studies have shown that exposure to adipocyte hypertrophy, the resulting 
hypoxia, and cellular apoptosis initiate a shift in the adipose tissue macrophage phenotype from 
anti-inflammatory (M2) to proinflammatory (M1) [McNelis and Olefsky, 2014]. This shift favors 
the production of cytokines such as Interleukin (IL)-1 beta (IL-1β), IL-6, and Tumor necrosis 
factor—alpha (TNF-α) that are known to perpetuate systemic low-grade inflammation [Esser et 
al., 2014]. IL-6 is one of the most important factors involved in induction of synthesis of CRP, 
an acute phase reactant. Thus, chronic elevation of IL-6 results in elevated CRP levels, making it 
an excellent marker for inflammation [Camelo et al., 2014]. Normal concentrations of CRP in 
humans are considered to be <10 mg/L, with levels >10 mg/L indicative of a source of infection 
or inflammation [Aronson et al., 2004; Seyeda et al., 2014]. Elevated CRP has been observed in 
individuals with obesity and metabolic syndrome [Aronson et al., 2004] and several 
epidemiologic studies have shown that elevations in CRP are related to CVD [Ridker et 
al., 1997; Ridker and Haughie, 1998; Rost et al., 2001], even predicting future mortality from 
cardiovascular events in apparently healthy adults [Ridker et al., 2002; Pai et al., 2004]. The in 
vivo half-life of this peptide is 19 hr [Foglar and Lindsey, 1998], which suggests that even 
transient elevations will be observable for several days and may reflect altered risk for CVD. 
Smoking is one of the main causes of preventable illnesses in the world [Rom et al., 2015a], and 
is generally thought to be pro-inflammatory, raising systemic levels of cytokines, and other 
inflammatory markers [Rom et al., 2013]. Smoking is also known to alter metabolism such that 
smokers have lower BMI and lower lean mass but higher central adiposity [Rom et al., 2015b]. 
Several studies have shown elevated CRP in smokers in the general population [Shiels et 
al., 2014; Loprinzi and Walker, 2015; Rom et al., 2015a], but the relationship appears to be 
strongest in long-term habitual smokers with high pack-year histories [Loprinzi and 
Walker, 2015; Rom et al., 2015b]. One study showed that CRP is elevated at a very low 
threshold (1–10 cigarettes per day), suggesting that even a low degree of exposure to cigarette 
smoke may alter the systemic levels of inflammatory markers [Shiels et al., 2014]. Since 
smoking prevalence is significantly higher in long-haul truck drivers compared to the general 
adult working population [Sieber et al., 2014; Birdsey et al., 2015], smoking may play an 
important role in CRP levels in this particular sub-group of the population. 
Obesity rates in long-haul truck drivers or other categories of commercial drivers have 
consistently been shown to be significantly higher than the rates observed in the general 
population. In several recent studies, only 20.8% of truck drivers were found to have a healthy 
weight [Sangaleti et al., 2014], and greater than 60% were either overweight or obese [Saberi et 
al., 2011; Rosso et al., 2015] . Some of these studies additionally assessed waist circumference 
and found similar results, with 58–68% of drivers having a waist circumference greater than 
102 cm [Saberi et al., 2011; Sangaleti et al., 2014]. While waist circumference is widely used for 
assessing abdominal obesity, some studies have shown that sagittal diameter is correlated more 
strongly with cardiovascular risk than either waist circumference or BMI [Ehrlich and 
Smith, 2011; Vidigal et al., 2013] and should be investigated as an alternative for waist 
circumference in assessing risk associated with centralized obesity. 
Sleep is generally considered restorative and reduced sleep duration has been associated with 
increased cardiovascular morbidity [Hoevenaar-Blom et al., 2014], while sleep restriction has 
been shown to elevate CRP [Meier-Ewert et al., 2004]. In a study simulating accumulated sleep 
loss across 5 work days, CRP concentrations increased 145% over baseline and continued to rise 
to 231% over baseline after two nights of recovery sleep [van Leeuwen et al., 2009]. In studies 
documenting sleep duration in long-haul truck drivers, sleep duration averaged 3.8–5.2 hr per 
day [Apostolopoulos et al., 2010], similar to the 4 hr per night allowed in the sleep loss 
simulation. Given this consistent sleep deprivation in truck drivers, it is expected that CRP levels 
would be higher than the general population. 
Commercial drivers have a high prevalence of risk factors for CVD, including sedentary 
lifestyle, poor eating habits, obesity, high blood pressure, smoking, poor sleep habits, and 
chronic stress [Robinson and Burnett, 2005; Apostolopoulos et al., 2010; Sangaleti et al., 2014] 
and trucking is classified as one of the highest-risk occupations in the United States 
[Apostolopoulos et al., 2010]. However, lack of empirical data investigating likely mechanisms 
for increased risk of cardiovascular disease in long-haul truck drivers may inhibit the ability of 
researchers, governments and businesses to design and implement optimal intervention strategies 
aimed at reducing CVD in this particular occupational segment. The purpose of the current study 
was to investigate acute phase inflammatory levels, as assessed by CRP concentrations, in long-
haul truck drivers. We hypothesized that long-haul truck drivers with the highest levels of 
general obesity and abdominal adiposity would have higher concentrations of CRP. 
MATERIALS AND METHODS 
Study Procedures 
Approval of all procedures was obtained from the Institutional Review Board of the University 
of North Carolina Greensboro. A non-experimental descriptive, cross-sectional design was 
employed in this pilot study to collect survey and anthropometric data from 262 long-haul 
truckers at a major truck stop located in central North Carolina over a 6-month time frame. Using 
intercept techniques, researchers approached drivers and asked several screening questions to 
determine whether they would be eligible for inclusion in this study. We estimate that 
approximately 50% of the drivers who were approached met the inclusion criteria and agreed to 
participate in the study. To be included drivers were required to be long-haul, meaning that they 
spend consecutive nights away from home, and they had to be spending the night at the truck 
stop where data collection took place, so that fasting blood samples could be taken the following 
morning before they got back on the road. With Type I error set at 0.05 and power at 90%, our 
likely sample size was anticipated to enable us to conduct appropriate statistical analyses, 
including examining significant differences among predictor and outcome variables. Using 
intercept techniques, researchers approached drivers between 1800 and 2200 hr and asked 
screening questions to determine eligibility for inclusion in to the study. Those drivers who were 
long-haul truckers, who were planning to spend the night at the truck stop and leaving between 
0400 and 0800 hr the following morning were enrolled in the study. All aspects of study 
participation were explained and drivers interested in participating were asked to read and sign 
an informed consent. Drivers were allowed to use aliases to assure greater confidentiality and/or 
anonymity. Using a privacy screen in a low traffic area of the truck stop, the weight of each truck 
driver was recorded in kg to the nearest 0.1 kg with shoes off using an Elite XXL scale. Height 
was measured to the nearest cm using a portable stadiometer (Seca, Chino, CA). BMI (kg/m2) 
was calculated and rounded to one decimal. 
Circumference measures were assessed using a Gulick II tape measure with tension indicator and 
values recorded to a single decimal. Each measure was taken two times and averaged. Waist and 
hip circumference were assessed as outlined by the standardization reference manual [Callaway 
et al., 1988]. Briefly, waist circumference was assessed at the natural waist (smallest 
circumference), while hip circumference was assessed with clothes on at the level of the 
maximum extension of the buttocks. Sagittal diameter was measured to the nearest tenth of a 
centimeter at the level of the umbilicus [approximating the L4-L5 level of the spine] using a 
Rosscraft Campbell caliper #20 (Vancouver, BC). When the level of the umbilicus was altered 
by the presence of abdominal folds, the tops of the iliac crest were palpated and the sagittal 
measure was taken at this level. Subjects were asked to breathe normally for several breaths 
before a value was taken. 
Sample Characteristics 
Data for demographic and lifestyle variables that could potentially be related to CRP in long-haul 
truck drivers were collected. We developed the Trucker Sleep Disorders Survey from insights 
gleaned from other key instruments (i.e., Basic Nordic Sleep Questionnaire, Berlin 
Questionnaire), relevant sleep literature, and our previous work with truck drivers [Partinen and 
Gislason, 1995; Netzer et al., 1999; Philip and Åkerstedt, 2006; Ursin et al., 2009]. The Trucker 
Sleep Disorders Survey was organized into five sections, which assessed: (i) trucking work 
environment, including work hours, workplace characteristics, workload, job strain, and 
schedules; (ii) individual work- and health-related factors, including sociodemographics, 
psychosocial factors, dietary and physical activity patterns, substance use patterns, sleep patterns, 
and health history; (iii) self-reported sleep disturbances and sleep disorders; (iv) self-reported 
health consequences resulting from sleep disorders; and (v) self-reported comorbidities 
associated with chronic sleep disorders. Key variables included smoking status, average hours of 
nightly sleep (including both working and non-working nights), average daily work hours, 
diabetic status, anti-inflammatory medication use, and ethnic identification. Participants were 
asked if they smoked cigarettes, and if so, the number of packs per day. However, given the large 
proportion of non-smokers and the low variability in reported volume among users, smoking 
status was dichotomized into smoker/non-smoker and this was used in all analyses. Information 
on smoking history was not collected since current smoking is most influential for inflammatory 
status [Rom et al., 2015a] and over time, smoking cessation results in inflammatory markers 
reverting back to levels observed in never smokers [Shiels et al., 2014]. Ethnic identification was 
coded as White/other than White. Diabetes diagnosis information and anti-inflammatory usage 
information were provided via self-report, and dichotomized into diabetic/non-diabetic and 
user/non-user for anti-inflammatory medication (i.e., ibuprofen, aspirin, non-steroidal anti-
inflammatory drugs, etc.). 
Blood Draws 
After completing all questionnaires and measurements, the drivers were given an appointment 
card for the following morning and instructed to fast for at least 8 hr or the remainder of the 
evening, whichever was longer. Of the 262 truck drivers that completed questionnaires and 
anthropometric measures, only 115 truck drivers returned for blood draws the following morning 
and were provided with a snack immediately after the blood draw was completed. Following 
Occupational and Safety Health Administration (OSHA) procedures [United States Department 
of Labor, 2003] blood was taken from the antecubital space in either arm using aseptic technique 
by a trained research technician. Blood was collected in red top tubes and allowed to clot at room 
temperature for 15–20 min. Using a portable centrifuge (LW Scientific E8 Portafuge, Atlanta, 
GA), blood samples were spun at 3,000 rpm for 15 min and then transported on ice to the 
laboratory. Serum was divided into aliquots and stored at −80°C for future analysis. 
Blood Analysis 
High sensitivity C-reactive protein (CRP) values were assessed using ELISA (Calbiotech, Spring 
Valley, CA). The minimum detectable dose of the assay is 0.005 μg/ml and inter-assay variance 
was 9%. 
Anthropometric Indices 
Given the extremely high prevalence of overweight and obesity in truck drivers, we were 
interested in identifying simple anthropometric measures such as waist circumference or sagittal 
diameter that could be utilized in this group to screen drivers with the highest risk for long term 
health complications. The most widely used anthropometric index is BMI, but as part of the 
current study, we calculated three additional anthropometric indices. The waist-to-height ratio, 
was calculated as the waist circumference (cm) divided by the height (cm) and the sagittal 
diameter-to-height ratio, was calculated as the sagittal abdominal diameter (cm) divided by the 
height (m). The conicity index (COI) [Vidigal et al., 2013] was calculated as follows; 
 
NHANES Data 
Since minimal data are available on the normative values for cardiometabolic risk factors in 
commercial drivers, we wanted to compare the values obtained in the drivers to the U.S. general 
population and we felt that the National Health and Nutrition Examination Survey (NHANES) 
provided the best comparison. Unfortunately, while the 2011–2012 NHANES data provided 
sagittal diameter values, these data did not include CRP. Therefore, we went to the most recent 
NHANES data that included CRP values (2009–2010). Thus, total datasets from two different 
NHANES groups (2009–2010 and 2011–2012), were filtered to include only males above 18 
years of age. There were no changes to inclusion made for BMI, waist circumference, or sagittal 
diameter. Only NHANES participants who gave blood samples were included from the 
NHANES 2009 to 2010 group for comparison of CRP. The final number included in each 
sample was n = 3106 from NHANES 2009 to 2010 and n = 2594 from NHANES 2011 to 2012. 
Statistical Analysis 
Between-groups comparisons of long-haul truck drivers who did and did not complete blood 
draws were carried out using one-way analysis of variance (ANOVA), testing for differences in 
traditional (BMI, waist circumference, hip circumference, and sagittal diameter) and non-
traditional anthropometrics (waist-to-height ratio, sagittal diameter-to-height ratio, and conicity 
index), resting HR, and resting BP. Single-sample t-tests were then used to test for differences in 
traditional anthropometrics between the entire sample of long-haul truck drivers and mean 
population values that were estimated using data from the NHANES 2011 to 2012 cohort. A 
second single-sample t-test was carried out to test whether the drivers who completed blood 
draws exhibited differences in CRP values from the mean population values estimated using the 
NHANES 2009–2010 cohort. NHANES sample weighting was taken into account when 
estimating all population values. Bonferroni corrections were applied to the threshold to achieve 
statistical significance within each set of comparisons. 
The distribution of CRP values was expectedly non-normal; therefore, a logarithmic 
transformation was applied, and Q-Q plots examined to ensure the transformed distribution met 
normality assumptions [Ghasemi and Zahediasl, 2012]. All anthropometric variables were 
standardized, such that unit change reflected increases or decreases in standard deviations. 
Correlational analyses were used to test for bivariate relationships among individual 
anthropometric variables and log-adjusted CRP values, and between potential covariates and log-
adjusted CRP. Pearson product moment correlations were calculated when both variables were 
continuous (i.e., sleep, work hours), and point biserial correlations calculated when one variable 
was dichotomous (i.e., smoking status, ethnic identification, anti-inflammatory medication use, 
and diabetic status). A series of 3-step hierarchical linear regression analyses was then conducted 
to determine the extent to which each anthropometric variable predicted log-adjusted CRP 
values: a separate hierarchical regression model was estimated for each anthropometric measure. 
Potential covariates were entered into the regression models at step 1. Only those covariates for 
which the bivariate correlation with log-adjusted CRP achieved at least marginal significance 
(P ≤ 0.10) were included in the models; thus, the included covariates and results for step 1 were 
identical for each model. The anthropometric variable was entered at step 2. Finally, the square 
of the anthropometric value was entered at step 3 to test for quadratic associations with log-
adjusted CRP. 
RESULTS 
While many long-haul truck drivers agreed to participate in the questionnaire and anthropometric 
portion of the study, slightly fewer than half the truckers (N = 115; 43.9%), returned the 
following morning for a fasted blood draw (Table I). Three subjects from the non-blood draw 
group had missing anthropometric variables and were excluded from the analysis. When 
comparing anthropometrics, resting heart rate, or resting blood pressure (BP), the group that 
returned for a blood draw was not significantly different on any variable compared to the 
individuals who did not return for a blood draw the following morning. The drivers who returned 
for a blood draw in the morning were slightly older (47.8 vs. 45.7 years) and had slightly higher 
resting diastolic BP (82.8 vs. 80.6 mmHg), but neither of these differences was significant 
(P = 0.113 and P = 0.119, respectively). The drivers who returned for blood draws were slightly 
less likely to be smokers than the drivers who did not return for blood draws (35.7% vs. 43.8%, 
respectively), but this difference was not significant (P = 0.204). While the average BMI for both 
groups was 33.4, there were 17 drivers (11.8%) in the normal BMI range (18–25) in the group 
that did not have morning blood draws and only 10 drivers (8.7%) with a BMI were in the 
normal range among the drivers with blood draws. Thus, 88.2% of the drivers who did not return 
for morning blood draws were overweight or obese by BMI criteria, compared to 91.3% of the 
drivers who had blood draws; both values that are consistently higher than the general 
population. To further compare our long-haul truck driver population to the general population, 
we looked at NHANES (2011–2012) anthropometric data for individuals with similar 
demographics (see methods for specific details), and found that long-haul truck drivers had 
consistently higher BMI (33.4 ± 7.2 vs. 28.3 ± 5.8, P < 0.001), waist circumference (114.8 ± 16.6 
vs. 100.5 ± 9.1, P < 0.001) and sagittal diameter (32.3 ± 5.8 vs. 23.1 ± 4.3, P < 0.001), compared 
to the individuals in this NHANES cohort. 
Table I. Anthropometric Characteristics and Resting Heart Rate and Blood Pressure for Long-
Haul Truck Drivers With and Without a Blood Draw 
  No blood 
draw 
(N = 144) 
Blood draw 
(N = 115) 
P-value 
Age 45.7 (11.1) 47.8 (9.7) 0.113 
Height (cm) 180.1 (7.5) 179.1 (7.8) 0.305 
Weight (kg) 108.7 (26.1) 107.3 (22.3) 0.658 
Body mass index (kg/m2) 33.4 (7.65) 33.4 (6.70) 0.972 
Resting heart rate (bpm) 77.5 (13.1) 77.9 (12.2) 0.778 
Systolic blood pressure 
(mm Hg) 
128.5 (18.2) 129.3 (19.3) 0.725 
Diastolic blood pressure 
(mm Hg) 
80.6 (11.2) 82.8 (11.4) 0.119 
Waist circumference (cm) 114.6 (17.0) 115.0 (16.1) 0.831 
Sagittal abdominal 
diameter (cm) 
32.20 (5.83) 32.41 (5.68) 0.771 
Hip circumference (cm) 115.6 (13.9) 114.6 (13.8) 0.575 
Waist-to-height ratio 0.637 (0.094) 0.643 (0.091) 0.599 
Conicity index 1.358 (0.083) 1.366 (0.083) 0.469 
Sagittal diameter-to-height 
ratio 
17.89 (3.24) 18.11 (3.20) 0.589 
Values are mean (SD). 
When considering the long-haul truck driver CRP values, only 16 drivers or 13.9% had CRP 
values <1 mg/L, while 23 drivers (20%) had values in the 1–3 mg/L range. Interestingly, 43 long-
haul truck drivers (37.4%) had CRP values between 3 and 10 mg/L and another 33 (28.7%) had 
values between 10 and 100 mg/L. Thus, 66.1 % of the drivers had elevated CRP concentrations 
(>3 mg/L). Figure 1 demonstrates mean CRP concentrations and mean sagittal diameter values 
based on standard BMI categories. 
 
Figure 1. Mean fasting C-reactive protein (CRP) level assessed in serum (mg/L) and the sagittal 
abdominal diameter (SAD) (cm) in long-haul truck drivers stratified by BMI category. 
All bivariate correlations with log-adjusted CRP are listed in Table II. Pearson product-moment 
correlational analysis revealed that all anthropometric variables were positively associated with 
log-adjusted CRP (r values ranged from 0.184 to 0.316), and statistically significant (P values 
ranged from 0.001 to 0.048). Alternatively, correlations between other sample characteristics and 
log-adjusted CRP were non-significant, with only smoking status achieving marginal 
significance (P = 0.055). Therefore, smoking status was the only covariate meeting the threshold 
for inclusion and was entered into each regression at step 1. At step 1, the model was marginally 
significant (P = 0.055), with smoking status accounting for approximately 2.4% of the variability 
in log-adjusted CRP. The addition of an anthropometric variable at step 2 yielded statistically 
significant models (P ≤ 0.015), in which both smoking status (P ≤ 0.034) and the anthropometric 
(P ≤ 0.03) were significantly and positively predictive of log-adjusted CRP. Quadratic terms 
added at step 3 all failed to reach significance as individual predictors and resulted in either no 
change in, or decrements to, the overall models. A summary of regression results at step 2 are 
provided in Table III, and tests of quadratic associations failed to reach significance or improve 
any of the models at step 3. 
Table II. Bivariate Correlations With Log-Adjusted C-Reactive Protein 
  Corr. P-
value 
N 
 
Covariate 
Smoking* 0.180 0.055 115 
Sleep −0.047 0.620 115 
White* −0.018 0.845 115 
Work hours 0.029 0.759 115 
Diabetes* −0.138 0.145 113 
Anti-inflammatories* −0.056 0.551 115 
Obesity measure 
Body mass index 0.303 0.001 115 
Sagittal diameter 0.283 0.002 115 
Waist circumference (cm) 0.269 0.004 115 
Hip circumference (cm) 0.235 0.011 115 
Weight-to-height ratio 0.274 0.003 115 
Waist-to-height ratio 0.310 0.001 115 
Conicity index 0.184 0.048 115 
Sagittal diameter-to-height 
ratio 
0.316 0.001 115 
*Point biserial correlation. 
Table III. Predictive Capacity of Anthropometric Measures for Log-Adjusted C-Reactive 
Protein 
Model Anthropometric β CI95% P-value R2adj. R2adj.Δ 
1. Body mass index 0.198 0.097–0.299 <0.001 0.131 0.107 
  Smoking 0.284 0.073–0.494 0.009     
2. Sagittal diameter 0.182 0.080–0.284 0.001 0.114 0.090 
  Smoking 0.270 0.058–0.482 0.013     
3. Waist circumference (cm) 0.179 0.076–0.281 0.001 0.110 0.086 
  Smoking 0.281 0.067–0.494 0.010     
4. Hip circumference (cm) 0.158 0.054–0.261 0.003 0.089 0.065 
  Smoking 0.271 0.055–0.486 0.014     
5. Weight-to-height ratio 0.185 0.083–0.288 0.001 0.116 0.092 
  Smoking 0.289 0.076–0.503 0.008     
6. Waist-to-height ratio 0.197 0.096–0.298 <0.001 0.131 0.107 
  Smoking 0.272 0.063–0.482 0.011     
7. Conicity index 0.116 0.011–0.220 0.030 0.056 0.032 
  Smoking 0.235 0.019–0.452 0.034     
8. Sagittal diameter-to-height 
ratio 
0.196 0.096–0.297 <0.001 0.131 0.107 
  Smoking 0.262 0.053–0.471 0.014     
*CI95%, 95% confidence interval; R2adj., Adjusted R2: which reflects the total variance 
(adjusted for sample size) in log-adjusted CRP accounted for by the model at step 2 of each 
regression analysis. R2adj.Δ, Change in adjusted R2: which reflects the variance in log-adjusted 
CRP accounted for by the anthropometric variable once the contribution of smoking status has 
been subtracted out. 
DISCUSSION 
As a next step to understanding the possible pathways involved in the cardiovascular risk 
stratification of commercial drivers, the objective of the current study was to assess the 
inflammatory status of long-haul truck drivers as it relates to obesity. To our knowledge, this is 
the first study to assess inflammatory status in long-haul truck drivers and the primary findings 
from our study can be summarized as follows; (i) significant elevations (above 3 mg/L) in high 
sensitivity-CRP (mean 8.825 mg/L) were found in approximately two-thirds of all long-haul 
truck drivers; (ii) BMI, waist circumference and sagittal diameter were significantly higher than 
the values reported for the general population; (iii) among the anthropometric variables and 
indices investigated, variables that included height (BMI, waist-to-height ratio, and sagittal 
diameter-to-height ratio) were better predictors of adjusted CRP values than other 
anthropometric variables; and (iv) 10% of the variability in the CRP values was accounted for by 
the anthropometric indices (either BMI, waist-to-height ratio or sagittal diameter-to-height ratio). 
Long-haul truck drivers represent a unique cohort, both within the occupational segment of 
commercial drivers and within the general population. First, these drivers are uniquely dependent 
on their worksites: Unlike other occupations, long-haul truck drivers may not return home for 
weeks at a time, spending not only their working hours but the majority of their non-working 
hours in worksite environments [Apostolopoulos et al., 2014]. These worksites offer very little 
health-supportive options, especially in dietary options and opportunities for physical activity 
[Apostolopoulos et al., 2012, 2011a]. Further, due to productivity pressures (especially mile-
based compensation), drivers engage in health-compromising behavior such as excessively 
speeding, working when fatigued, and circumventing HOS rules [Centers for Disease Control 
and Prevention, 2007; Krueger et al., 2007; Apostolopoulos et al., 2010, 2011b; Shattell et 
al., 2010]. Despite regulatory limits on driving hours in the U.S., long-haul drivers typically 
work long and irregular hours [Puhkala et al., 2015], resulting in disrupted circadian rhythms, 
inadequate sleep, sleep disorders, and excessive daytime sleepiness, which can have significant 
negative impacts on long-haul truckers’ mental and physical health [Krueger et al., 2007; 
Apostolopoulos et al., 2010]. 
When circadian misalignment occurs, energy metabolism is altered and shift-type work has been 
associated with chronic desynchronization between internal and external timing 
[Szosland, 2010]. This sets up a hormonal milieu that may alter appetite-related input to the 
hypothalamus, resulting in altered energy balance [Marqueze et al., 2012], and; ultimately, body 
weight and other cardiovascular risk factors will be affected. Making matters worse, many long-
haul drivers lack basic health insurance coverage, and work hours make it difficult to seek 
medical care [Apostolopoulos et al., 2013]. Despite these dramatic health disparities, efforts to 
mitigate the multiple deleterious impacts on driver health endemic to the long-haul trucking 
profession, particularly those associated with working conditions of drivers, have been sporadic 
and piecemeal [Lemke and Apostolopoulos, 2015]. 
Obesity rates have become endemic to almost all parts of the world, but data from previous 
studies [Moreno et al., 2006; Martin et al., 2009; Saberi et al., 2011; Apostolopoulos et al., 2013; 
Sangaleti et al., 2014; Sieber et al., 2014; Rosso et al., 2015] and the current investigation 
suggest that long-haul truck drivers are significantly more obese than the general population. 
Abdominal obesity was highly prevalent in our group of drivers. Utilizing the standardized waist 
circumference cutoff for increased risk of heart disease of 102 cm [American College of Sports 
Medicine, 2014], 79.2% of our cohort met the criteria for increased risk. In a recent study of 
sagittal diameter as a screening tool for cardiometabolic risk, the authors suggested a cut-off of 
22 cm for the highest risk quintile for men [Riserus et al., 2010]. In the current cohort of long-
haul truck drivers, the mean value for sagittal diameter in every BMI group (including normal 
BMI), was above this 22 cm cut-off (Fig. 1). While individuals with sagittal diameters below 
22 cm were present in our cohort, almost all of our truck drivers would have met the criteria for 
“metabolically obese” as outlined by Riserus and associates [Riserus et al., 2010]. Even when the 
more liberal sagittal diameter cutoff of 25 cm, suggested by Pouliot and associates [Pouliot et 
al., 1994] to be indicative of increased accumulation of visceral adipose tissue, was used as the 
cut point, 90% of our cohort met the criteria for increased risk. 
When considering anthropometric measures, both waist circumference and sagittal diameter are 
relatively simple measures that require minimal equipment and training, a single measurement 
and no calculations, but sagittal diameter has consistently been shown to be more indicative of 
markers of glucose intolerance [Riserus et al., 2010] and CVD risk [Riserus et al., 2010; de 
Souza and de Oliveira, 2013], especially in men [Carlsson et al., 2013]. Given the work 
constraints placed on long-haul truck drivers, brevity of assessment may be a key factor for 
maximizing participation in research and using a single anthropometric measure that maximizes 
health risk assessment would be optimal. We would recommend the use of sagittal diameter in 
future studies that assess health risk in commercial vehicle drivers, especially when insulin 
sensitivity or glucose tolerance and the associated CVD risk are of primary interest. 
In the current study of long-haul truck drivers, CRP values did not increase in a linear fashion 
across BMI categories. Individuals with Class I and II obesity had similar CRP values despite the 
fact that sagittal diameter values were steadily increasing. Both obesity (BMI) [Aronson et 
al., 2004] and sagittal diameter (abdominal obesity) [Vidigal et al., 2013] have been shown to be 
associated with elevated CRP, but our data suggest that substantially increasing both results in 
the most sizeable elevations in CRP. It is also notable that in our cohort, the CRP values were 
higher in the normal weight compared to the overweight category. The individuals in the normal 
weight category had a higher prevalence of smoking (50.0%), than the overweight individuals 
(35.7%), which likely explains this difference. BMI, waist-to-height ratio and sagittal diameter-
to-height ratio each explained the same amount of variance (∼10%) in the current study, but as 
in another study [Aronson et al., 2004] each still accounted for only a small amount of the 
overall variance in the CRP values. BMI, waist-to-height ratio and sagittal diameter-to-height 
ratio have the disadvantage that two measurements need be taken and ratios calculated, which is 
an additional source of potential error These anthropometric indices accounted for only slightly 
more of the variance in CRP than sagittal diameter by itself (9%). 
The mean CRP concentration for our cohort of drivers (8.825 ± 9.962 mg/L), was considerably 
higher than the mean CRP concentrations reported for a similar cohort from the 2009 to 2010 
NHANES (3.158 ± 6.990 mg/L, P < 0.001) and consistently higher than most studies that have 
assessed CRP in various populations [Aronson et al., 2004; Vidigal et al., 2013; Camelo et 
al., 2014; Tully et al., 2015]. Similar to Aronson et al., [2004], levels of CRP suggesting a source 
of infection or inflammation (>10 mg/L), were most common in individuals with the highest 
levels of obesity. Although some epidemiological studies have advocated the removal of data 
points >10 mg/L, since they reflect acute inflammatory conditions, the number of values above 
this range in the current study suggests that higher CRP values may be very common in this 
population. Whether or not these values are tied to specific active inflammatory conditions 
cannot be answered by our study and perhaps is somewhat irrelevant. When only 16 individuals 
out of 115 have a value <1 mg/L, the overarching conclusion should be that this cohort of 
individuals represents a unique and highly risky profile of metabolic factors known to be tied to 
CVD. 
Since there are numerous factors that influence inflammatory status of individuals, we 
investigated the role of smoking status, sleep hours, ethnicity, work hours, diabetes status, and 
concomitant use of anti-inflammatory medication on CRP values. In our analysis, only smoking 
status trended toward a significant correlation with CRP. While other studies have found 
smoking status to influence CRP [Loprinzi, 2015; Loprinzi and Walker, 2015; Rom et al., 2015a] 
or other inflammatory markers [Shiels et al., 2014], we did not find this to be the case in our 
cohort. Many individuals provided incomplete information related to smoking and we did not 
collect information on past smoking history, both of which may have influenced our ability to 
observe this relationship. However, the strongest negative effects of smoking on CRP values 
appear to occur in current heavy smokers [Loprinzi and Walker, 2015; Rom et al., 2015a] and 
our population contained few current heavy smokers (only 7.3% of truckers smoked more than 
one pack per day). 
Another important consideration for CRP values in long-haul truck drivers is related to second 
hand smoke exposure and environmental exposure to particulate matter. Compared to the general 
population, long-haul truck drivers have very high smoking rates (∼50%) [Sieber et al., 2014; 
Birdsey et al., 2015] and even short term second hand smoke exposure has been shown to elevate 
CRP [Zhang et al., 2013], such that even non-smoking long-haul truck drivers may have elevated 
CRP. 
Although the studies relating air pollution to CRP are very limited [Rückerl et al., 2014; 
Viehmann et al., 2015], preliminary evidence suggests that exposure to particulate matter may 
result in considerable elevations in CRP. Cumulatively, these studies may help explain the 
relatively high CRP levels that were very common in our cohort. Lastly, we assessed only CRP 
and while it is a very good measure of systemic inflammation, assessing other inflammatory 
biomarkers (either pro- or anti-inflammatory) may provide a more accurate picture of the 
inflammatory milieu in long-haul truck drivers. 
One major limitation of the current study is that we employed a sampling technique that involved 
blood draws in the actual trucking environment (truck stop). While this minimized barriers to 
participation and likely increased the willingness of truck drivers to be involved in the study, it 
often did not allow the drivers to fast for at least 8 hr prior to a blood draw. Most truck drivers in 
our cohort fasted approximately 6 hr (coinciding with their total sleep time for the night). While 
we recognize that this may slightly alter our blood values, this shorter fasting time is 
representative of the usual schedule maintained by these individuals. 
Another limitation of the current study is the relatively small sample size of only 262 long-haul 
truck drivers and only 115 with fasted blood samples. While a larger sample size may have 
increased our likelihood of finding certain previously reported relationships, the congruency of 
our findings with other studies involving commercial vehicle drivers indicates that our sample 
was highly representative of the population. The potential for selection bias is an important 
consideration when interpreting our results. Drivers refusing to participate may have done so for 
myriad reasons. For example, given the increasingly-stringent medical requirements that drivers 
must meet to operate a commercial motor vehicle, drivers may have been concerned that results 
from the current study may have resulted in disqualification or termination. Drivers may have 
also been leery of releasing any personal information to a government entity, including the 
University conducting this study. Our own extensive experience with collecting data from this 
population has indicated the presence of a certain level of mistrust among many drivers, and 
similar feedback was received from non-participating drivers informally in the current study as 
well. 
In conclusion, the current study assessing the levels of CRP as a marker of inflammation in 
relation to obesity in long-haul truck drivers has clearly shown that abdominal obesity is not only 
highly prevalent in commercial vehicle drivers, but the CRP values are significantly elevated in 
this group. Future studies that include larger cohorts are necessary to further investigate the 
potential negative health impact of significant elevations of CRP in long-haul truck drivers. 
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